Abstract: A method is described for processing keyed data items that are each associated with a value of a key, the keyed data items being from a plurality of distinct data streams, the processing including collecting the keyed data items, determining, based on contents of at least one of the keyed data items, satisfaction of one or more specified conditions for execution of one or more actions and causing execution of at least one of the one or more actions responsive to the determining.

Abstract: A device to assemble a skin and a frame of an aircraft fuselage. The device includes first and second brace members that extend along opposing sides of a gap. Arches are spaced apart and fixedly connected to the first and second brace members and that extend across the gap. A strongback is attached to and movable along the first and second brace members with the strongback having a curved shape that matches the plurality of arches. The strongback includes clamps configured to engage with the frame. First and second tension devices apply tension to the skin at the strongback.

Abstract: Anhydrous formulations are formed of a diblock copolymer (X-Y) having a hydrophilic block X comprising residues of monomer x, and a hydrophobic block Y comprising residues of monomer y; an additive selected from a polymer and an organic solvent, where the solvent is water-miscible and biocompatible, and the polymer is hydrophobic or hydrophilic and comprises residues of monomers x and/or y, the polymer optionally having a molecular weight that is less than the molecular weight of the diblock copolymer; and a drug. Upon admixture with water, the anhydrous formulations form drug delivery vehicles, preferably in micellar form. The inclusion of polymer and/or organic solvent provides for the formation of micelles at an enhanced rate, and/or provides the formation of micelles having an enhanced ability to incorporate drug(s), and/or provides the formation of micelles having advantageous physical characteristics, e.g., advantageous viscosity and/or melting point.

Abstract: Anhydrous formulations are formed of a diblock copolymer (X—Y) having a hydrophilic block X comprising residues of monomer x, and a hydrophobic block Y comprising residues of monomer y; an additive selected from a polymer and an organic solvent, where the solvent is water-miscible and biocompatible, and the polymer is hydrophobic or hydrophilic and comprises residues of monomers x and/or y, the polymer optionally having a molecular weight that is less than the molecular weight of the diblock copolymer; and a drug. Upon admixture with water, the anhydrous formulations form drug delivery vehicles, preferably in micellar form. The inclusion of polymer and/or organic solvent provides for the formation of micelles at an enhanced rate, and/or provides the formation of micelles having an enhanced ability to incorporate drug(s), and/or provides the formation of micelles having advantageous physical characteristics, e.g., advantageous viscosity and/or melting point.

Abstract: An animal litter composition comprised of a liquid absorbent aggregate impregnated with an agent to indicate the presence of sugar in the urine of felines and other related species includes 88.1 percent +/?5.0 percent by weight of an expanded aggregate, 00.9 percent +/?0.7 percent by weight of an odor control/antistatic agent, 07.0 percent +/?4.0 percent by weight of a clumping agent, 03.0 percent +/?2.5 percent by weight of a surfactant; and 01.0 percent +/?0.90 percent by weight of a glucosuria indicator. A method of detecting glucosuria in a feline includes providing the animal litter in a litter box or in an enclosure in which the feline is restrained until the feline urinates on the litter and then visually observing the litter for a color change.

Abstract: A motorized operator for moving a barrier, such as an upward acting garage door, between open and closed positions includes a support mounted adjacent one of a pair of barrier guide tracks or along a barrier counterbalance shaft and a drive mechanism mounted on the support and engaged with an elongated flexible member, such as a chain, cable or cog belt. A cog belt, for example, is connected to a drawbar connected to the barrier at one end and the belt is either connected directly to the barrier at the opposite end or to a storage reel supported for rotation on and with a shaft of a barrier counterbalance mechanism. The storage reel may include a spiral groove and be supported on the counterbalance shaft for axial translation to receive and dereel the belt as the barrier is moved between open and closed positions. One or more belt tensioning pulleys may be mounted on the support.

Abstract: A barrier operator includes a drive motor and a controller for causing the motor to move the barrier between open and closed positions and for monitoring parameters related to forces acting on the barrier during movement thereof. If no external entrapment device is connected to the controller, the controller automatically sets maximum control limit values which will effect stopping or reversing of the motor if an obstruction is encountered by the barrier. If an external entrapment device is connected to the controller, the controller requires a user to set the control limit values at least for movement of the barrier from an open position to a closed position. Audio or visual signal indicators associated with the controller alert the user to the requirement to set the control limits before the operator will effect movement of the barrier.

Abstract: Low cost, low power consumption radio frequency transceivers are incorporated in barrier operator control systems for transmitting signals between an operator control unit, one or more remote control units, a diagnostic or calibration device and an obstruction detector. Similar detector devices, including such transceivers, may be employed in loading docks for detecting the status of dock levelers and vehicle restraint devices. Radio frequency communication eliminates the need for hard wiring and also provides for transmission of commands and status information between various control units.

Abstract: Anhydrous formulations are formed of a diblock copolymer (X-Y) having a hydrophilic block X comprising residues of monomer x, and a hydrophobic block Y comprising residues of monomer y; an additive selected from a polymer and an organic solvent, where the solvent is water-miscible and biocompatible, and the polymer is hydrophobic or hydrophilic and comprises residues of monomers x and/or y, the polymer optionally having a molecular weight that is less than the molecular weight of the diblock copolymer; and a drug. Upon admixture with water, the anhydrous formulations form drug delivery vehicles, preferably in micellar form. The inclusion of polymer and/or organic solvent provides for the formation of micelles at an enhanced rate, and/or provides the formation of micelles having an enhanced ability to incorporate drug(s), and/or provides the formation of micelles having advantageous physical characteristics, e.g., advantageous viscosity and/or melting point.

Abstract: Anhydrous formulations are formed of a diblock copolymer (X-Y) having a hydrophilic block X comprising residues of monomer x, and a hydrophobic block Y comprising residues of monomer y; an additive selected from a polymer and an organic solvent, where the solvent is water-miscible and biocompatible, and the polymer is hydrophobic or hydrophilic and comprises residues of monomers x and/or y, the polymer optionally having a molecular weight that is less than the molecular weight of the diblock copolymer; and a drug. Upon admixture with water, the anhydrous formulations form drug delivery vehicles, preferably in micellar form. The inclusion of polymer and/or organic solvent provides for the formation of micelles at an enhanced rate, and/or provides the formation of micelles having an enhanced ability to incorporate drug(s), and/or provides the formation of micelles having advantageous physical characteristics, e.g., advantageous viscosity and/or melting point.

Abstract: Improved aqueous gliadin-containing cosmetic formulations are provided which include form about 0.5-10% by weight gliadin dispersed in an aqueous solvent system together with additional ingredients giving desired end properties. The formulations are preferably selected from the group consisting of hairsprays, hair shampoos and shampoo conditioners, hair styling gels, hair conditioners, instant conditioners, and hair reparatives, as well as sunscreens, shaving creams and bath and shower gels.

Abstract: Improved aqueous gliadin-containing hairspray formulations are provided which include form about 0.5-10% by weight gliadin dispersed in an aqueous alcohol-containing solvent system at a pH of from about 3-5.5. The preferred formulations have a VOC content of up to about 55% and contain little or no synthetic polymer.